Related Experiment Video

Updated: Jul 10, 2026

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma

Tsuyoshi Fukushima1, Hiroaki Kataoka

  • 1Section of Oncopathology and Regenerative Biology, Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.

Anticancer Research
|November 1, 2007
PubMed

Insights

Insulin-like growth factor binding protein-2 (IGFBP-2) influences cancer growth. This review explores IGFBP-2

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Insulin-like growth factor binding protein-2 (IGFBP-2) modulates insulin-like growth factor (IGF) actions.
  • IGFBP-2 exhibits IGF-independent effects on cell proliferation, apoptosis, and motility.
  • Overexpression of IGFBP-2 is observed in glioblastoma multiforme (GBM), a highly malignant brain tumor.

Purpose of the Study:

  • To review the IGF-dependent and -independent functions of IGFBP-2.
  • To focus on the specific roles of IGFBP-2 in GBM progression.

Main Methods:

  • Literature review of existing studies on IGFBP-2.
  • Analysis of research on IGFBP-2's involvement in cancer, particularly GBM.

Main Results:

  • IGFBP-2 has both IGF-dependent and IGF-independent roles in cellular functions.
  • IGFBP-2 is implicated in the aggressive characteristics of GBM, including rapid growth, invasiveness, and angiogenesis.

Conclusions:

  • IGFBP-2 plays a significant role in the malignant progression of glioblastoma multiforme.
  • Further research is needed to fully elucidate the mechanisms by which IGFBP-2 contributes to GBM.
  • Targeting IGFBP-2 may offer potential therapeutic strategies for GBM.

More Related Videos

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...